• DocumentCode
    1526188
  • Title

    Computing in drug discovery: the design phase

  • Author

    Lunney, Elizabeth A.

  • Author_Institution
    Pfizer Global Res. & Dev., San Diego, CA, USA
  • Volume
    3
  • Issue
    5
  • fYear
    2001
  • Firstpage
    105
  • Lastpage
    108
  • Abstract
    Drug discovery is an extended process that can take as many as 15 years from the first compound synthesis in the laboratory until the therapeutic agent, or drug, is brought to market. Reducing the research timeline in the discovery stage is a key priority for pharmaceutical companies worldwide, and through the application and collaboration of current, advanced technologies, the industry is poised to achieve that goal. This article highlights computational chemistry, a technology that can play an important role in expediting the drug design phase
  • Keywords
    biology computing; chemistry computing; pharmaceutical industry; computational chemistry; design phase; drug design; drug discovery; laboratory; pharmaceutical companies; Biological system modeling; Biology computing; Collaboration; Crystallography; Drugs; Hydrogen; Laboratories; Nuclear magnetic resonance; Proteins; Spectroscopy;
  • fLanguage
    English
  • Journal_Title
    Computing in Science & Engineering
  • Publisher
    ieee
  • ISSN
    1521-9615
  • Type

    jour

  • DOI
    10.1109/5992.947114
  • Filename
    947114